Literature DB >> 23714314

Inherited disorders of platelets: membrane glycoprotein disorders.

Reyhan Diz-Kücükkaya1, José A López.   

Abstract

Platelet membrane glycoproteins play a key role in hemostasis and thrombosis. Although disorders of platelet membrane glycoproteins are rare, their effects on the lives of those affected are very important. Severe deficiencies manifest themselves early during childhood with mucocutaneous bleeding. Mild deficiencies may not be diagnosed until adulthood or until the hemostatic system is stressed by surgery or trauma. The diagnosis of these disorders requires detailed laboratory investigation. Management of bleeding in patients with inherited platelet disorders requires both preventive measures and the treatment of individual bleeding episodes according to severity. The study of platelet membrane disorders also has yielded important insights into the functions of affected proteins, information that has produced some of the most successful antithrombotic drugs currently in use.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23714314     DOI: 10.1016/j.hoc.2013.03.005

Source DB:  PubMed          Journal:  Hematol Oncol Clin North Am        ISSN: 0889-8588            Impact factor:   3.722


  3 in total

1.  Parsing the repertoire of GPIb-IX-V disorders.

Authors:  A Koneti Rao; Natthapol Songdej
Journal:  Blood       Date:  2017-01-26       Impact factor: 22.113

2.  Bernard Soulier Syndrome: 10 years' experience at a tertiary care hospital.

Authors:  Saima Farhan; Irem Iqbal; Nisar Ahmed
Journal:  Pak J Med Sci       Date:  2019       Impact factor: 1.088

3.  The Copenhagen founder variant GP1BA c.58T>G is the most frequent cause of inherited thrombocytopenia in Denmark.

Authors:  Eva Leinøe; Nanna Brøns; Andreas Ørslev Rasmussen; Migle Gabrielaite; Carlo Zaninetti; Raghavendra Palankar; Eva Zetterberg; Steen Rosthøj; Sisse Rye Ostrowski; Maria Rossing
Journal:  J Thromb Haemost       Date:  2021-08-11       Impact factor: 16.036

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.